View of INTERFERON I AS A THERAPEUTIC TARGET IN THE TREATMENT OF SYSTEMIC LUPUS ERYTHEMATOSUS: USE OF MONOCLONAL ANTIBODIES ANIFROLUMAB, RONTALIZUMAB AND SIFALIMUMAB

Return to Article Details INTERFERON I AS A THERAPEUTIC TARGET IN THE TREATMENT OF SYSTEMIC LUPUS ERYTHEMATOSUS: USE OF MONOCLONAL ANTIBODIES ANIFROLUMAB, RONTALIZUMAB AND SIFALIMUMAB Download Download PDF